Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsIn 2022, ADL BIONATUR SOLUT.EO-,05 has already paid €0.13 in dividends. The last payout was in June 2022.
Financials
In the last quarter, ADL BIONATUR SOLUT.EO-,05 had revenue of €874.64K and net profit of -€1.18M
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 874.64K | - |
| Gross profit | -900.71K | - |
| Net profit | -1.18M | - |
| EBITDA | -346.3K | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €16.26M |
Number of shares | 75.98M |
52-week high/low | €0.32 - €0.18 |
| Dividends | No |
Beta | 1.82 |
P/E ratio | -6.97 |
PEG ratio | 7.16 |
P/B ratio | 2.92 |
P/S ratio | 5.45 |
Company profile
Biotechnologies Assets SA develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.
| Name | ADL BIONATUR SOLUT.EO-,05 |
| CEO | Manuel Lopez Nieto |
| Headquarters | Cádiz,
an Spain |
| Website | |
| IPO | 01/26/2012 |
| Employees | 26 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Bme | BST.MC |
Madrid | BST.MC |